Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald S Nuzum

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|July 11, 2006
Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka, Donald S Nuzum, Jamie L Jolly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 8, 2011
Risk of cancer associated with the use of angiotensin II-receptor blockersJacqueline L Olin, Angie Veverka, Donald S Nuzum
Vascular Health and Risk Management|April 2, 2009
Long-acting nifedipine in the management of the hypertensive patientMorgan E Snider, Donald S Nuzum, Angie Veverka
The Annals of Pharmacotherapy|November 20, 2018
Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination TabletDawn Battise, Cassie L Boland, Donald S Nuzum
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 17, 2014
Alternative dosing strategies for liraglutide in patients with type 2 diabetes mellitusAdriane B Marino, Sabrina W Cole, Donald S Nuzum
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 24, 2018
Oral ivermectin for the treatment of head lice infestationWendy L Sanchezruiz, Donald S Nuzum, Samir A Kouzi
The Annals of Pharmacotherapy|April 4, 2013
Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitorsCassie L Boland, Michelle Degeeter, Donald S Nuzum, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|January 18, 2008
Cardiovascular medication prescribing in older adults with psychiatric disordersChristian R Dolder, Angie Veverka, Donald S Nuzum, et al.
American Journal of Pharmaceutical Education|February 19, 2016
Creating and Assessing Student Perception of an Examination Mastery Score Report for a Pharmacotherapy CourseGreg L Alston, Donald S Nuzum, Angela Pegram, et al.
Frontiers in Bioscience (Elite Edition)|January 2, 2015
Natural supplements for improving insulin sensitivity and glucose uptake in skeletal muscleSamir A Kouzi, Sendra Yang, Donald S Nuzum, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|July 11, 2006
Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka, Donald S Nuzum, Jamie L Jolly
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 8, 2011
Risk of cancer associated with the use of angiotensin II-receptor blockersJacqueline L Olin, Angie Veverka, Donald S Nuzum
Vascular Health and Risk Management|April 2, 2009
Long-acting nifedipine in the management of the hypertensive patientMorgan E Snider, Donald S Nuzum, Angie Veverka
The Annals of Pharmacotherapy|November 20, 2018
Nebivolol/Valsartan: A Novel Antihypertensive Fixed-Dose Combination TabletDawn Battise, Cassie L Boland, Donald S Nuzum
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 17, 2014
Alternative dosing strategies for liraglutide in patients with type 2 diabetes mellitusAdriane B Marino, Sabrina W Cole, Donald S Nuzum
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 24, 2018
Oral ivermectin for the treatment of head lice infestationWendy L Sanchezruiz, Donald S Nuzum, Samir A Kouzi
The Annals of Pharmacotherapy|April 4, 2013
Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitorsCassie L Boland, Michelle Degeeter, Donald S Nuzum, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|January 18, 2008
Cardiovascular medication prescribing in older adults with psychiatric disordersChristian R Dolder, Angie Veverka, Donald S Nuzum, et al.
American Journal of Pharmaceutical Education|February 19, 2016
Creating and Assessing Student Perception of an Examination Mastery Score Report for a Pharmacotherapy CourseGreg L Alston, Donald S Nuzum, Angela Pegram, et al.
Frontiers in Bioscience (Elite Edition)|January 2, 2015
Natural supplements for improving insulin sensitivity and glucose uptake in skeletal muscleSamir A Kouzi, Sendra Yang, Donald S Nuzum, et al.
Pageof 2